NFE2L2 and Alzheimer disease: Recent studies have recognized Nrf2 as a key upstream regulator of cytokine production, laying the groundwork for Nrf2-mediated anti-inflammatory strategies relevant to neuroinflammation in AD (Kobayashi et al., 2016).